Tocilizumab Biosimilar - Research Grade

Human

IL-6 receptor

1.0 - 5.0 mg/ml

Human IgG1 Kappa

Humanized

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human IL-6 receptor. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Tocilizumab.

Blue ice

The interleukin-6 receptor (IL-6R) mediates the activity of the pleiotropic cytokine IL-6 and is a key target in inflammation and autoimmunity research. This research-grade anti-human IL-6R recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of tocilizumab, built around the IL-6 receptor for research use only. Manufactured to in vivo standards as an ultra-pure, low-endotoxin human IgG1-kappa, it is supplied in scalable milligram to gram quantities for high-throughput and bulk laboratories. It serves as a dependable control and active reagent across preclinical applications, including receptor-blocking assays, in vitro screening of IL-6 signalling, and in vivo inflammatory disease models.

IL6R

P08887

ICH3001-100ml ICH3002-100ml ICH3003-100ml

https://www.imgt.org/mAb-DB/